Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (89)

« Back to Publications

Ambulatory Blood Pressure Patterns and Left Ventricular Mass Index in Tanzanian Adults Living with and without HIV.

Willkens M. et al, (2026), Glob Heart, 21

Diagnostic Performance of Unattended Automated Office Blood Pressure Measurement for Hypertension Screening Among People With and Without HIV.

Lucinde RK. et al, (2025), J Am Heart Assoc, 14

Hypertension in Sub-Saharan Africa: Burden, Barriers and Priorities for Improving Treatment Outcomes.

Jobe M. et al, (2025), Circ Res, 137, 106 - 118

Hepatitis B Core-Related Antigen Point-of-Care Tests as a Risk Stratification Tool for Treatment Eligibility: Experience From Kenya.

Downs LO. et al, (2025), Open Forum Infect Dis, 12

Active vaccine safety surveillance: Experience from a prospective cohort event monitoring study of COVID-19 vaccines in Kenya.

Odhiambo DB. et al, (2025), PLOS Glob Public Health, 5

Implementation strategies to improve outcomes in patients with established cardiovascular disease in sub-Saharan Africa: A systematic review.

Sanga LA. et al, (2025), PLOS Glob Public Health, 5

Hepatitis B core-related antigen (HBcrAg) point-of-care tests as a risk stratification tool: experience from Kenya

Downs LO. et al, (2024)

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

Evaluating the implementation of the Primary Health Integrated Care Project for Chronic Conditions: a cohort study from Kenya.

Mugo R. et al, (2024), BMJ Public Health, 2

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya.

Downs LO. et al, (2023), J Virus Erad, 9

Cardiovascular Health Priorities in Sub-Saharan Africa

Obonyo NG. and Etyang AO., (2023), SN Comprehensive Clinical Medicine, 5

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

Hamaluba M. et al, (2023), Wellcome Open Research, 8

Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study.

Otiende M. et al, (2023), Nat Commun, 14

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022.

Kagucia EW. et al, (2023), Influenza Other Respir Viruses, 17

Load More

1
2
3
4
5
6